Pulmonary hypertension is severe complication of hematopoietic stem cell transplantation in children that is often underestimated.
Researchers evaluated whether cardiopulmonary exercise testing could improve the performance of the DETECT screening approach in systemic sclerosis-related pulmonary arterial hypertension.
In patients with pulmonary arterial hypertension, cardiac magnetic resonance imaging metrics are capable of identifying individuals at a low risk for 1-year mortality.
This study assessed improvement in pulmonary vascular resistance and cardiac index in patients with pulmonary arterial hypertension who rapidly inhale iloprost 2.5 ug via the Breelib™ nebulizer.
The FDA has approved the supplemental NDA for Orenitram extended-release tablets for the treatment of PAH to delay disease progression, in addition to improving exercise capacity.
Investigators sought to determine whether growth differentiation factor-15 is a significant prognostic biomarker in pulmonary hypertension.
For patients with inoperable or residual postendarterectomy chronic thromboembolic pulmonary hypertension, performing a balloon pulmonary angioplasty provided improvements in pressure measurements, functional class, and exercise capacity with an acceptable risk profile.
Persistent pulmonary hypertension is strong predictor of mortality in older patients who underwent ASD closure.